Volume Alert - GILD 100.39 Gilead Sciences $GILD Hit a high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 11:07 AM

Volume Alert - GILD 100.39 Gilead Sciences $GILD Hit a high today of 103.79 Closing the day 10:30 at 100.39 -3.81 -3.66% With a day low of 100.06 and a total volume of 8,270,259.

GILD Recent Posts: http://investorshangout.com/Gilead-Sciences-Inc-GILD-54232/

GILD Gilead Sciences Recent Headline News

Early Glance: Biotechnology companies
AP - 19 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)

Gilead Sciences (GILD) Crosses Pivot Point Support at $102.79
Comtex SmarTrend(R) - 1 hr 9 mins ago
Shares of Gilead Sciences (NASDAQ:GILD) opened today below their pivot of $104.92 and have already reached the first level of support at $102.79. Investors may be interested in a cross of the next downside pivot targets of $101.38 and $97.84.
GILD: 101.28 (-2.92)

Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences
Alexander J. Poulos - Seeking Alpha - 1 hr 43 mins ago
It is not often for one to come across such an explosive growth company such as Gilead Sciences (NASDAQ: GILD ). By virtue of its stronghold on the Hepatitis C market (HCV) combined with its dominant share in the HIV market, GILD has many...
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), SNY: 46.49 (-0.04), REGN: 400.16 (-2.47)

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - 1 hr 56 mins ago
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 101.28 (-2.92), IBIO: 1.10 (+0.02), ARIA: 6.18 (-0.07), MNKD: 6.23 (+0.05), CELG: 103.40 (-4.03)

Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
PR Newswire - 2 hrs 21 mins ago
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: BlackBerry (NASDAQ:BBRY), Twitter (NYSE:TWTR), Alibaba (NYSE:BABA), Sirius XM (NASDAQ:SIRI), Gilead Sciences (NASDAQ:GILD), and JD.Com (NASDAQ:JD).
GILD: 101.28 (-2.92), BBRY: 11.63 (-0.43), JD: 26.45 (-0.87), TWTR: 40.69 (+0.65), SIRI: 3.52 (+0.01), BABA: 114.69 (-0.15)

The Post AASLD Annual Meeting Hepatitis C Landscape
Leonard Yaffe - at Seeking Alpha - Fri Nov 14, 5:15AM CST

JNJ: 108.59 (-0.48), GILD: 101.28 (-2.92), MRK: 58.97 (-0.57), ABBV: 63.44 (-0.19)

If Gilead Has The Ace, Is AbbVie Holding The Big Joker?
Shock Exchange - at Seeking Alpha - Fri Nov 14, 1:55AM CST

GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)

Most active Nasdaq-traded stocks
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.28 (-2.92), FB: 74.57 (+0.32), CMCSK: 54.05 (+0.02), ZNGA: 2.71 (-0.02), MSFT: 49.93 (+0.32), INTC: 33.87 (+0.19), GRPN: 7.79 (+0.02), CMCSA: 54.21 (-0.09), AAPL: 113.95 (+1.13), SUSQ: 13.12 (+0.06), CSCO: 26.05 (+0.37)

Final Glance: Biotechnology companies
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)

Midday Glance: Biotechnology companies
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)

Gilead prices debt offering
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:19AM CST

GILD: 101.28 (-2.92)

Why Gilead Sciences (GILD) Isn't Done Growing Earnings Yet - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:44AM CST
Gilead Sciences which is in the Biotechnology space, saw EPS growth of nearly 11% last year, and is looking great for this year too.
GILD: 101.28 (-2.92)

Gilead prices USD4bn senior unsecured notes in three tranches
M2 - Thu Nov 13, 6:01AM CST
Biopharmaceutical company Gilead Sciences (NasdaqGS:GILD) said on Wednesday that it has priced its USD4bn senior unsecured notes in a public offering.
GILD: 101.28 (-2.92)

Gilead Prices $4 Billion of Senior Unsecured Notes
Business Wire - Wed Nov 12, 4:59PM CST
Gilead Sciences, Inc. (NASDAQ: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten, registered public offering, consisting of three tranches:
GILD: 101.28 (-2.92)

Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 4:00PM CST
Gilead Sciences, Inc. (GILD) announced pooled data from certain phase II and phase III studies evaluating Harvoni.
AGN: 197.30 (+1.09), JNJ: 108.59 (-0.48), GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)

Gilead Sciences Falls 1.03% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 12, 3:37PM CST
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $105.70 to a high of $107.81. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $106.33 on volume of 12.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GILD: 101.28 (-2.92)

Look for Shares of Gilead Sciences to Potentially Rebound after Yesterday's 1.03% Sell Off
Comtex SmarTrend(R) - Wed Nov 12, 3:37PM CST
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $105.70 to a high of $107.81. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $106.33 on volume of 12.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GILD: 101.28 (-2.92)

Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie
Small Pharma Analyst - at Seeking Alpha - Wed Nov 12, 2:25PM CST

GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)

Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View
Shock Exchange - at Seeking Alpha - Wed Nov 12, 2:13PM CST

GILD: 101.28 (-2.92), MRK: 58.97 (-0.57)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ABVC BioPharma Raises $3.39M in Private Placement

Dollar Signs and Big Plans: ABVC's Private Placement ABVC BioPharma just bagged $3.39 million through a private placement of senior convertible promissory notes. This ain’t your average financing move, folks. We’re talking original issue discount notes at a hefty 17.5%, maturing by June 2027. This deal takes the cake for today's big plays. Why This Matters to...

Watches of Switzerland Dazzles with Holiday Campaign

Swiss Timepieces Take Center Stage Ever feel like there's a certain art to gift-giving? Apparently, The Watches of Switzerland Group thinks so, and they're not holding back in showing us how it's done with their new 'Brilliantly Given' campaign. They’re taking a classic approach by spotlighting luxury timepieces and fine jewelry just in time for the holiday...

Strategic Leap: Context Labs Sets Roots in Abu Dhabi

Breaking New Ground in AI Infrastructure Well, folks, we're witnessing an intriguing strategic move here that could potentially reshape the AI landscape across the MENA region. Context Labs, the masterminds behind the AI Data Infrastructure, have roped in a powerful ally in the form of 22/x, a frontrunner in the Abu Dhabi investment scene. And no, this isn't just about...

TikTok-Coda: A New Era for Digital Commerce

Redefining Commerce in the Digital Age Alright, folks, let's chew the fat over something that's flipping the script on digital commerce. Coda, the Southeast Asian powerhouse in digital content monetization, is stirring things up with TikTok Gaming. Since June, it's been cooking up one billion views worth of creative potential from users, tightening the grip on digital...

Texas A&M, Natura Tackle Nuclear Waste Recycling

Ambitious Nuclear Fuel Recycling Underway Talk about turning trash into treasure. Natura Resources has teamed up with Texas A&M in a bold project aiming to recycle nuclear waste into usable fuel for new reactors. They've got federal backing to the tune of $5.4 million, courtesy of the U.S. Department of Energy. This effort to harness old nuclear waste has the potential to...

LITEON's Q3 Surge: Record Profits, AI Focus Amplified

LITEON Smashes Q3 Records, Financials Speak Volumes You don't find numbers like these under every rock. LITEON Technology is rolling in it after clinching third quarter revenues of NT$57.4 billion, marking a significant 9% growth compared to the previous quarter and a whopping 28% surge year-over-year. That's the kind of financial football that gets investors holding onto...

Potomac Edison Targets Virginia Grid Revamp by 2030

Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...

FFR Sets New Sales Record, Eyes Market Expansion

FFR Breaks New Ground With Record Sales Something big's brewing at FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR), and it's causing quite the ripple. Picture this: 351 devices shipped in October alone. That's a hill-climbing record for this newbie on the U.S. stock scene. February was their starting line, and they've zoomed past 1,000 units in cumulative sales, chalking up...

UFC Gym Expands, Opening Murfreesboro Location Soon

UFC GYM Targets the Heart of Murfreesboro They're doing it again—UFC GYM's tossing another gym into the mix, folks! This time, it's Murfreesboro, Tennessee, catching the brand's punchy, high-energy splash. Don't mistake this for just another big-box, bench-press-jamboree. Their doors swing open come November 14, and this ain't some punk move. We're talking a whopping...

MDP+ Expands to U.S. with Nordstrom Launch

Picture a new player stepping onto the bustling U.S. skincare scene—Korean brand MDP+ is taking its swing at the American market through its fresh debut at Nordstrom. Now, this is more than just another cream in the aisle; it spells a strategic push into department stores, expanding the retail game's stakes for MDP+ beyond the digital shelves of Amazon and TikTok Shop....